about
Expression and regulation of GFRalpha3, a glial cell line-derived neurotrophic factor family receptorReduced antinociception and plasma extravasation in mice lacking a neuropeptide Y receptorDistinct roles of Bcl-2 and Bcl-Xl in the apoptosis of human bone marrow mesenchymal stem cells during differentiation.New lines of GFP transgenic rats relevant for regenerative medicine and gene therapy.Local control of the host immune response performed with mesenchymal stem cells: perspectives for functional intracerebral xenotransplantationEffects of Human Alpha-Synuclein A53T-A30P Mutations on SVZ and Local Olfactory Bulb Cell Proliferation in a Transgenic Rat Model of Parkinson Disease.Intracerebral xenotransplantation: recent findings and perspectives for local immunosuppression.Attenuation of hypercholesterolemia and hyperglycemia in ob/ob mice by NPY Y2 receptor ablation.Enteric glial cells have specific immunosuppressive properties.Transgenic expression of CTLA4-Ig by fetal pig neurons for xenotransplantation.Ectopic expression of the TrkA receptor in adult dopaminergic mesencephalic neurons promotes retrograde axonal NGF transport and NGF-dependent neuroprotection.Cell Therapy for Parkinson's Disease: A Translational Approach to Assess the Role of Local and Systemic Immunosuppression.Cytotoxic effects of 1 alpha,25-dihydroxyvitamin D3 and synthetic vitamin D3 analogues on a glioma cell line.Induction of glioma cell death by 1,25(OH)2 vitamin D3: towards an endocrine therapy of brain tumors?Comparison of spheroids formed by rat glioma stem cells and neural stem cells reveals differences in glucose metabolism and promising therapeutic applications.Survival and differentiation of adenovirus-generated induced pluripotent stem cells transplanted into the rat striatum.1,25-Dihydroxyvitamin D3 regulates the expression of the low-affinity neurotrophin receptor.Distinct roles of the Y1 and Y2 receptors on neuropeptide Y-induced sensitization to sedation.IgG response to intracerebral xenotransplantation: specificity and role in the rejection of porcine neurons.Assessment of ethanol consumption and water drinking by NPY Y(2) receptor knockout mice.Colonic inflammation in Parkinson's disease.Low-Dose Pesticide Mixture Induces Senescence in Normal Mesenchymal Stem Cells (MSC) and Promotes Tumorigenic Phenotype in Premalignant MSC.Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor.Glioplasticity in irritable bowel syndrome.1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells.Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation.L. fermentum CECT 5716 prevents stress-induced intestinal barrier dysfunction in newborn rats.Complementary and overlapping expression of Y1, Y2 and Y5 receptors in the developing and adult mouse nervous system.Assessing the potential clinical utility of transplantations of neural and mesenchymal stem cells for treating neurodegenerative diseases.Regulation of NGF, BDNF and LNGFR gene expression in ROS 17/2.8 cells.1,25-dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes.Expression of the nerve growth factor gene is controlled by the microtubule networkA theory that may explain the Hayflick limit — a means to delete one copy of a repeating sequence during each cell cycle in certain human cells such as fibroblastsPhosphatidylcholine-phospholipase C mediates the induction of nerve growth factor in cultured glial cellsPathological lesions in colonic biopsies during Parkinson's diseaseComplex interactions among second messenger pathways, steroid hormones, and protooncogenes of the Fos and Jun families converge in the regulation of the nerve growth factor geneExpression of 25(OH) vitamin D3 24-hydroxylase gene in glial cellsDecreased choline acetyltransferase activity in nerve growth factor-transgenic mice during brain developmentImmunoregulatory properties of neural stem cellsThe multiple faces of inflammatory enteric glial cells: is Crohn's disease a gliopathy?
P50
Q24682581-C0036DD3-1B8C-4260-B6A0-65B65976516DQ28593004-49BBE278-CFE0-4CA5-A12B-1CF8D005F68FQ33903974-FCFFA18A-788F-432E-99CA-7A5500CD74CBQ34020966-53017918-7F03-47DC-9687-CD5D802180A4Q34885388-2F317597-D4D3-423E-A1C2-C65E66E6E331Q35101612-74356EE8-B071-4DF7-A24B-C72D831475D0Q37854404-603885CB-F9CC-4BFE-9666-0D824C663CD3Q38364124-75B624AC-CE28-41A8-85D8-EEC13A184921Q39729587-7D9D21E0-3148-46D4-8D25-9D9021F270AEQ40384077-6B440DA9-0376-4757-B4D5-C79072654A63Q40627081-AAC89EC0-82A7-415A-AAC0-8DFF06782D33Q40839095-807CE88D-CB4A-44BF-99B6-C3F61B140D3FQ41226433-A822B98B-DAA0-4610-9D39-59E97E0DD35CQ41490937-3E396BC0-A97C-4B7A-A292-D66A44150FDAQ42121672-CC30D9D4-9EC0-4C19-8590-D65881837C44Q42281985-55350BF3-CEA4-4712-8F7B-E8C413DE901BQ42552926-12947950-3B7F-403B-8DF2-993D71406C95Q43752317-DAC915FB-6164-4CEA-AA5F-7BE1CD7C61A3Q44567310-69C2388D-AB5B-4C2A-965D-9A1CA42AC5FAQ44941276-E8270CD7-B22A-4FCA-AD55-08E1BCE83A4CQ46015750-11E1EAB6-152A-4EF4-A05D-779269DECC47Q46458165-3D7F4FC8-E5C2-4388-BAD6-6CF42CF837D7Q47256568-DFED425F-2D0E-4F74-B512-B6DF5C37D423Q48020961-66930803-7816-49FD-B098-C498CD093C8FQ48096904-B555428A-E544-4F52-A46D-7DAD84299671Q48315552-91420401-904A-42F0-BCEB-44D435AAD7C8Q48331515-BD65C0D1-D4AA-4E50-AF6C-D7269F510FDDQ48403276-BA2FAD98-71A1-4D41-9B9E-F244C179DD1BQ48501958-8E2C5C54-D61B-42A0-8195-4AB54D6F03DCQ49120666-F546E9F8-0C8A-492E-B99D-A8240B12C504Q55481493-4B297C40-EC8E-4508-9BC0-7447831E0AD5Q60272428-FB9138F4-4577-4675-A0D5-C79E754E88BCQ60272442-DE7CE017-5847-49A0-81E6-6DB0C7F95FFCQ62398814-E76BA135-3E39-4ADF-A99A-9B1EB4B9D605Q64877902-BDB30E60-9180-4C76-A339-FC812CBFC7E9Q70661425-FC79B636-42AF-4A90-8334-2B0B5FA0FD55Q71608078-2D1A7EE6-725F-4676-80C1-3CC37E6AE243Q72432078-58E765B9-0F86-437F-8E46-D86DD0995CD0Q83981075-92F21C8C-9E26-4B21-9358-319B6B31B524Q88002259-E6200360-A9E4-4D85-A019-C876CDCF3DC5
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-4093-4513
@en
name
P Naveilhan
@ast
P Naveilhan
@en
P Naveilhan
@nl
type
label
P Naveilhan
@ast
P Naveilhan
@en
P Naveilhan
@nl
prefLabel
P Naveilhan
@ast
P Naveilhan
@en
P Naveilhan
@nl
P106
P31
P496
0000-0003-4093-4513